Literature DB >> 20865338

Connecting serum IGF-1, body size, and age in the domestic dog.

Kimberly A Greer1, Larry M Hughes, Michal M Masternak.   

Abstract

Many investigations in recent years have targeted understanding the genetic and biochemical basis of aging. Collectively, genetic factors and biological mechanisms appear to influence longevity in general and specifically; reduction of the insulin/IGF-1 signaling cascade has extended life span in diverse species. Genetic alteration of mammals for life extension indicates correlation to serum IGF-1 levels in mice, and IGF-1 levels have been demonstrated as a physiological predictor of frailty with aging in man. Longevity and aging data in the dog offer a close measure of the natural multifactorial longevity interactions of genetic influence, IGF-1 signaling, and environmental factors such as exposure, exercise, and lifestyle. The absence of genetic alteration more closely represents the human longevity status, and the unique species structure of the canine facilitates analyses not possible in other species. These investigations aimed to measure serum IGF-1 in numerous purebred and mixed-breed dogs of variable size and longevity in comparison to age, gender, and spay/neuter differences. The primary objective of this investigation was to determine plasma IGF-1 levels in the adult dog, including a wide range of breeds and adult body weight. The sample set includes animals ranging from just a few months of age through 204 months and ranging in size from 5 to 160 lb. Four groups were evaluated for serum IGF-1 levels, including intact and neutered males, and intact and spayed females. IGF-1 loss over time, as a function of age, decreases in all groups with significant differences between males and females. The relationship between IGF-1 and weight differs depending upon spay/neuter status, but there is an overall increase in IGF-1 levels with increasing weight. The data, currently being interrogated further for delineation of IGF-1 receptor variants and sex differences, are being collected longitudinally and explored for longevity associations previously unavailable in non-genetically modified mammals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865338      PMCID: PMC3168604          DOI: 10.1007/s11357-010-9182-4

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  42 in total

Review 1.  The endocrine regulation of aging by insulin-like signals.

Authors:  Marc Tatar; Andrzej Bartke; Adam Antebi
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

Review 2.  Frailty--the search for underlying causes.

Authors:  Jeremy Walston
Journal:  Sci Aging Knowledge Environ       Date:  2004-01-28

Review 3.  Birthweight, rapid growth, cancer, and longevity: a review.

Authors:  Thomas T Samaras; Harold Elrick; Lowell H Storms
Journal:  J Natl Med Assoc       Date:  2003-12       Impact factor: 1.798

Review 4.  Current status of efforts to measure and modulate the biological rate of aging.

Authors:  Huber R Warner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-07       Impact factor: 6.053

5.  Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.

Authors:  Iona Cheng; Daniel O Stram; Kathryn L Penney; Malcolm Pike; Loïc Le Marchand; Laurence N Kolonel; Joel Hirschhorn; David Altshuler; Brian E Henderson; Matthew L Freedman
Journal:  J Natl Cancer Inst       Date:  2006-01-18       Impact factor: 13.506

6.  Growth and growth hormone in the dog.

Authors:  R C Nap; J A Mol; H A Hazewinkel
Journal:  Vet Q       Date:  1994-04       Impact factor: 3.320

7.  A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans.

Authors:  J Z Morris; H A Tissenbaum; G Ruvkun
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

8.  Body size parallels insulin-like growth factor I levels but not growth hormone secretory capacity.

Authors:  J E Eigenmann; D F Patterson; E R Froesch
Journal:  Acta Endocrinol (Copenh)       Date:  1984-08

9.  Big mice die young: early life body weight predicts longevity in genetically heterogeneous mice.

Authors:  Richard A Miller; James M Harper; Andrzej Galecki; David T Burke
Journal:  Aging Cell       Date:  2002-10       Impact factor: 9.304

10.  Insulin-like growth factor I levels in proportionate dogs, chondrodystrophic dogs and in giant dogs.

Authors:  J E Eigenmann; A Amador; D F Patterson
Journal:  Acta Endocrinol (Copenh)       Date:  1988-05
View more
  31 in total

1.  Cellular energetics and mitochondrial uncoupling in canine aging.

Authors:  Justin W Nicholatos; Timothy M Robinette; Saurabh V P Tata; Jennifer D Yordy; Adam B Francisco; Michael Platov; Tiffany K Yeh; Olga R Ilkayeva; Frank K Huynh; Maxim Dokukin; Dmytro Volkov; Michael A Weinstein; Adam R Boyko; Richard A Miller; Igor Sokolov; Matthew D Hirschey; Sergiy Libert
Journal:  Geroscience       Date:  2019-04-01       Impact factor: 7.713

Review 2.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 3.  Mechanisms limiting body growth in mammals.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  Endocr Rev       Date:  2011-03-25       Impact factor: 19.871

Review 4.  A short life on the farm: aging and longevity in agricultural, large-bodied mammals.

Authors:  Jessica M Hoffman; Teresa G Valencak
Journal:  Geroscience       Date:  2020-05-02       Impact factor: 7.713

Review 5.  The somatotropic axis and aging: Benefits of endocrine defects.

Authors:  Andrzej Bartke; Edward O List; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2016-02-16       Impact factor: 2.372

Review 6.  The Companion Dog as a Model for the Longevity Dividend.

Authors:  Kate E Creevy; Steven N Austad; Jessica M Hoffman; Dan G O'Neill; Daniel E L Promislow
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

Review 7.  GH and ageing: Pitfalls and new insights.

Authors:  Andrzej Bartke; Justin Darcy
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2017-02-24       Impact factor: 4.690

8.  Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.

Authors:  Elizabeth Drake Brooks; Dianne Little; Ramamani Arumugam; Baodong Sun; Sarah Curtis; Amanda Demaster; Michael Maranzano; Mark W Jackson; Priya Kishnani; Michael S Freemark; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

Review 9.  Species differences in tumour responses to cancer chemotherapy.

Authors:  Jessica Lawrence; David Cameron; David Argyle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 10.  Molecular Mechanisms Determining Lifespan in Short- and Long-Lived Species.

Authors:  Xiao Tian; Andrei Seluanov; Vera Gorbunova
Journal:  Trends Endocrinol Metab       Date:  2017-09-07       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.